Smart deals start with the right connections.
Access 800+ qualified LPs through CQ’s Investor Database.

OrbiMed
Venture Capital Firm, Real Estate Investment, Asset Management, Private Credit Firm, Private Equity Firm
OrbiMed invests globally across the healthcare industry, from start-ups to large multinational corporations, through a range of private equity funds, public equity funds, and royalty/credit funds. The firm seeks to be a capital provider of choice, offering tailored financing solutions and extensive global team resources to build world-class healthcare companies.
Overview and Management
Establishment Year
Mission
Values
Investment Roles
Participant Demographics
Generational Wealth Planning
Risk Tolerance
References or Case Studies
Team Experience
Notable Achievements
Project Track Record
Exit Strategies
Legal, Compliance and Contact Information
Regulatory Registrations
Compliance History
Phone Number
Address
New York United States
Similar Investor Firms
Frequently Asked Questions
What is OrbiMed's mission in healthcare investment?
OrbiMed's mission is to drive innovation in the healthcare sector by addressing unmet medical needs and enhancing patient outcomes. The company focuses on investing globally in world-class healthcare companies to facilitate advancements in medical technology and treatments. - Focus on innovation - Address unmet medical needs - Global investment strategy
How does OrbiMed select healthcare companies for investment?
OrbiMed employs a rigorous selection process to identify and invest in healthcare companies that demonstrate potential for innovation and growth. The firm evaluates companies based on their technology, market potential, and management team to ensure impactful investments. - Comprehensive evaluation criteria - Focus on technology and market potential - Experienced management teams
What types of healthcare sectors does OrbiMed invest in?
OrbiMed invests in a diverse range of healthcare sectors, including biotechnology, pharmaceuticals, medical devices, and diagnostics. This broad approach allows the firm to support various innovations that can significantly improve patient care and outcomes. - Biotechnology - Pharmaceuticals - Medical devices and diagnostics